These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
506 related items for PubMed ID: 17983402
1. A decision tool for predicting sentinel node accuracy from breast tumor size and grade. Coombs N, Chen W, Taylor R, Boyages J. Breast J; 2007; 13(6):593-8. PubMed ID: 17983402 [Abstract] [Full Text] [Related]
2. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A, Taormina P, Gebbiab V, David M, Riili I, Lo Gerfo D, Casà L, Noto A. Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642 [Abstract] [Full Text] [Related]
3. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer. Lovrics PJ, Chen V, Coates G, Cornacchi SD, Goldsmith CH, Law C, Levine MN, Sanders K, Tandan VR. Ann Surg Oncol; 2004 Sep; 11(9):846-53. PubMed ID: 15313737 [Abstract] [Full Text] [Related]
4. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer. Barone JE, Tucker JB, Perez JM, Odom SR, Ghevariya V. Am Surg; 2005 Jan; 71(1):66-70. PubMed ID: 15757061 [Abstract] [Full Text] [Related]
5. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer. Tan YY, Wu CT, Fan YG, Hwang S, Ewing C, Lane K, Esserman L, Lu Y, Treseler P, Morita E, Leong SP. Breast J; 2005 Jan; 11(5):338-43. PubMed ID: 16174155 [Abstract] [Full Text] [Related]
6. Tumour size as a predictor of axillary node metastases in patients with breast cancer. Laura S, Coombs NJ, Ung O, Boyages J. ANZ J Surg; 2006 Nov; 76(11):1002-6. PubMed ID: 17054550 [Abstract] [Full Text] [Related]
7. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Gimbergues P, Abrial C, Durando X, Le Bouedec G, Cachin F, Penault-Llorca F, Mouret-Reynier MA, Kwiatkowski F, Maublant J, Tchirkov A, Dauplat J. Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507 [Abstract] [Full Text] [Related]
8. The prevalence of and risk factors for four or more metastatic axillary lymph nodes in breast cancer patients undergoing sentinel node biopsy. Leidenius M, Vaalavirta L, Heikkilä P, von Smitten K, Salmenkivi K. J Surg Oncol; 2008 Jul 01; 98(1):21-6. PubMed ID: 18484087 [Abstract] [Full Text] [Related]
9. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy. Kinoshita T, Takasugi M, Iwamoto E, Akashi-Tanaka S, Fukutomi T, Terui S. Am J Surg; 2006 Feb 01; 191(2):225-9. PubMed ID: 16442950 [Abstract] [Full Text] [Related]
10. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study. Classe JM, Loussouarn D, Campion L, Fiche M, Curtet C, Dravet F, Pioud R, Rousseau C, Resche I, Sagan C. Cancer; 2004 Mar 01; 100(5):935-41. PubMed ID: 14983488 [Abstract] [Full Text] [Related]
11. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study. Unal B, Gur AS, Beriwal S, Tang G, Johnson R, Ahrendt G, Bonaventura M, Soran A. Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1035-40. PubMed ID: 19327916 [Abstract] [Full Text] [Related]
12. Value of the sentinel lymph node procedure in patients with large size breast cancer. Lelievre L, Houvenaeghel G, Buttarelli M, Brenot-Rossi I, Huiart L, Tallet A, Tarpin C, Jacquemier J. Ann Surg Oncol; 2007 Feb 15; 14(2):621-6. PubMed ID: 17103062 [Abstract] [Full Text] [Related]
13. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Wong SL, Chao C, Edwards MJ, Tuttle TM, Noyes RD, Carlson DJ, Laidley AL, McGlothin TQ, Ley PB, Brown CM, Glaser RL, Pennington RE, Turk PS, Simpson D, McMasters KM. Am Surg; 2001 Jun 15; 67(6):522-6; discussion 527-8. PubMed ID: 11409798 [Abstract] [Full Text] [Related]
14. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery]. Martel P, Capdet J, Méry E, Zerdoud S, Ferron G, Rafii A, Roché H, Querleu D. Bull Cancer; 2008 Jun 15; 95(7):763-72. PubMed ID: 18755653 [Abstract] [Full Text] [Related]
15. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer. Gui GP, Joubert DJ, Reichert R, Ward A, Lakhani S, Osin P, Nerurkar A, A'Hern R, Benson K, Underwood SR. Eur J Surg Oncol; 2005 Sep 15; 31(7):707-14. PubMed ID: 15993028 [Abstract] [Full Text] [Related]
18. [Risk of stage underestimation of breast cancer by sentinel lymph node biopsy method]. Houvenaeghel G, Martino M, Jacquemier J, Moutardier V, Tallet A, Viens P, Puig B, Bardou VJ. Bull Cancer; 2003 May 15; 90(5):467-73. PubMed ID: 12850770 [Abstract] [Full Text] [Related]
19. Predictive model of axillary lymph node involvement in women with small invasive breast carcinoma: axillary metastases in breast carcinoma. Martin C, Cutuli B, Velten M. Cancer; 2002 Jan 15; 94(2):314-22. PubMed ID: 11900217 [Abstract] [Full Text] [Related]